<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02689700</url>
  </required_header>
  <id_info>
    <org_study_id>040713 FRA Mat Fet CMV Antib</org_study_id>
    <nct_id>NCT02689700</nct_id>
  </id_info>
  <brief_title>Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns</brief_title>
  <acronym>MoChi-HCMV</acronym>
  <official_title>Examination of Diaplacental Transfer of IgG-antibodies Against Human Cytomegalovirus (HCMV) and Varicella-Zoster-Virus (VZV) at Premature and Mature Newborns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine the total concentration of HCMV- and VZV-specific
      IgG-antibodies and the total concentration of neutralizing antibodies against HCMV in
      neonatal bloodstream depending on gestational age at birth.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For data gathering the investigators measure the main concentration of specific
      HCMV-/VZV-IgG-antibodies and the concentration of neutralizing IgG-antibodies against HCMV
      and VZV in maternal blood and in fetal bloodstream. Then the investigators compare the data
      of mother and newborn. Therefore, the investigators use the following blood samples:

      Mother: Venous blood sample taken at birth (+/- three days)

      Newborn: Blood sample of umbilical cord (= fetal bloodstream) taken immediately after birth.

      The investigators assign the data of each newborn (gestational age at birth) to the data of
      their respective mother for statistical evaluation. After finishing the study the
      investigators will destroy all residual blood.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To measure the concentration of specific HCMV-/VZV-IgG-antibodies in fetal bloodstream depending on gestational age at birth.</measure>
    <time_frame>Newborn: immediately after birth; Mother +/- 3 days at birth</time_frame>
    <description>Measurement of HCMV and VZV-antibodies in the fetal and the maternal circulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gauging the concentration of neutralizing IgG-antibodies against HCMV and VZV in fetal bloodstream depending on gestational age at birth.</measure>
    <time_frame>Newborn: immediately after birth; Mother +/- 3 days at birth</time_frame>
    <description>Measurement of neutralizing IgG-HCMV and VZV-antibodies in the fetal and the maternal circulation</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Materno-fetal Transfer of Anti-HCMV-IgG</condition>
  <condition>Materno-fetal Transfer of Anti-VZV-IgG</condition>
  <arm_group>
    <arm_group_label>HCMV antibody-transfer</arm_group_label>
    <description>Materno-fetal HCMV antibody-Transfer form 24-41 weeks of gestation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VZV antibody-transfer</arm_group_label>
    <description>Materno-fetal VZV antibody-Transfer form 24-41 weeks of gestation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood samples</intervention_name>
    <description>Taking blood form the umbilical cord (fetal circulation) and from the vein of the corresponding mother.</description>
    <arm_group_label>HCMV antibody-transfer</arm_group_label>
    <arm_group_label>VZV antibody-transfer</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Umbilical Cord blood; Blood from peripheral vene
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Approximately 450 mother-child-pairs seropositive for HCMV and/or VZV
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HCMV and/or VZV-seropositive pregnant woman who signed written informed consent form.

        Exclusion Criteria:

          -  Newborns of underage mothers.

          -  Newborns whose mother did not sign the written informed consent.

          -  Pregnant women with a known hereditary or acquired immune deficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>10 Minutes</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Horst Buxmann, PI</last_name>
    <phone>+49 69 6301</phone>
    <phone_ext>5524</phone_ext>
    <email>horst.buxmann@kgu.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clara A Lüdeke, SI</last_name>
    <phone>+49 17662403039</phone>
    <email>clara.luedeke@web.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinic of the Johann Wolfgang-Goethe Univeristy</name>
      <address>
        <city>Frankfurt/Main</city>
        <state>Hesse</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Horst Buxmann, Dr. med.</last_name>
      <phone>0049 69 6301</phone>
      <phone_ext>5247</phone_ext>
      <email>horst.buxmann@kgu.de</email>
    </contact>
    <contact_backup>
      <last_name>Rolf L Schloesser, Prof Dr med</last_name>
      <phone>0049 69 6301</phone>
      <phone_ext>5120</phone_ext>
      <email>rolf.schloesser@kgu.de</email>
    </contact_backup>
    <investigator>
      <last_name>Horst Buxmann, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hannah Hürter, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clara A Lüdeke, Cand. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Louwen, Prof Dr med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rolf L Schloesser, Prof Dr med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Holger F Rabenau, Prof Dr rer nat</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hanns Ackermann, Dr rer med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Hobbs JR, Davis JA. Serum gamma-G-globulin levels and gestational age in premature babies. Lancet. 1967 Apr 8;1(7493):757-9.</citation>
    <PMID>4164125</PMID>
  </results_reference>
  <results_reference>
    <citation>Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003 Jul 28;21(24):3365-9. Review.</citation>
    <PMID>12850341</PMID>
  </results_reference>
  <results_reference>
    <citation>Mussi-Pinhata MM, Pinto PC, Yamamoto AY, Berencsi K, de Souza CB, Andrea M, Duarte G, Jorge SM. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates. J Med Virol. 2003 Feb;69(2):232-9.</citation>
    <PMID>12683413</PMID>
  </results_reference>
  <results_reference>
    <citation>Linder N, Waintraub I, Smetana Z, Barzilai A, Lubin D, Mendelson E, Sirota L. Placental transfer and decay of varicella-zoster virus antibodies in preterm infants. J Pediatr. 2000 Jul;137(1):85-9.</citation>
    <PMID>10891827</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2016</study_first_submitted>
  <study_first_submitted_qc>February 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2016</study_first_posted>
  <last_update_submitted>March 4, 2017</last_update_submitted>
  <last_update_submitted_qc>March 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Dr. med. Horst Buxmann</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Human Cytomegalovirus</keyword>
  <keyword>Varicella Zoster Virus</keyword>
  <keyword>Materno-fetal antibody transfer</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Gestational age</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Herpes Zoster</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
    <mesh_term>Immunoglobulins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

